-
1
-
-
0026499738
-
Effects of citicoline in subcortical dementia associated with Parkinson's disease assessed by quantified electroencephalography
-
García-Mas A, Rossinol A, Roca M, Lozano R, Rosselló J, Llinàs J. Effects of citicoline in subcortical dementia associated with Parkinson's disease assessed by quantified electroencephalography. Clin Ther 1992; 14: 718-29.
-
(1992)
Clin Ther
, vol.14
, pp. 718-729
-
-
García-Mas, A.1
Rossinol, A.2
Roca, M.3
Lozano, R.4
Rosselló, J.5
Llinàs, J.6
-
3
-
-
0026395332
-
Efficacy of CDP-choline in the treatment of senile alterations in memory
-
De la Morena E. Efficacy of CDP-choline in the treatment of senile alterations in memory. Ann N Y Acad Sci 1991; 640: 233-6.
-
(1991)
Ann N Y Acad Sci
, vol.640
, pp. 233-236
-
-
De La Morena, E.1
-
4
-
-
0028848099
-
CDP-choline: Pharmacological and clinical review
-
Secades JJ, Frontera G. CDP-choline: pharmacological and clinical review. Methods Find Exp Clin Pharmacol 1995; 14 (Suppl B): 2-54.
-
(1995)
Methods Find Exp Clin Pharmacol
, vol.14
, Issue.SUPPL. B
, pp. 2-54
-
-
Secades, J.J.1
Frontera, G.2
-
5
-
-
0027451394
-
Oral cytidine 5′-diphosphate choline administration to rats increases brain phospholipid levels
-
Agut J, López-Coviella I, Ortiz JA, Wurtman RJ. Oral cytidine 5′-diphosphate choline administration to rats increases brain phospholipid levels. Ann N Y Acad Sci 1993; 695: 318-20.
-
(1993)
Ann N Y Acad Sci
, vol.695
, pp. 318-320
-
-
Agut, J.1
López-Coviella, I.2
Ortiz, J.A.3
Wurtman, R.J.4
-
6
-
-
0028896412
-
Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline
-
Weiss GB. Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline. Life Sci 1995; 56: 637-60.
-
(1995)
Life Sci
, vol.56
, pp. 637-660
-
-
Weiss, G.B.1
-
8
-
-
0015157079
-
Brain lipid changes following hypoxia
-
Yatsu FM, Mosa SA. Brain lipid changes following hypoxia. Stroke 1971; 2: 587-93.
-
(1971)
Stroke
, vol.2
, pp. 587-593
-
-
Yatsu, F.M.1
Mosa, S.A.2
-
9
-
-
0019856239
-
Effect of cytidine diphosphate choline (CDP-choline) on ischemia-induced alterations of brain lipid in the gerbil
-
Trovarelli G, DeMedio GE, Dorman RV, Piccinin GL, Horrocks LA, Porcellati G. Effect of cytidine diphosphate choline (CDP-choline) on ischemia-induced alterations of brain lipid in the gerbil. Neurochem Res 1981; 6: 821-33.
-
(1981)
Neurochem Res
, vol.6
, pp. 821-833
-
-
Trovarelli, G.1
DeMedio, G.E.2
Dorman, R.V.3
Piccinin, G.L.4
Horrocks, L.A.5
Porcellati, G.6
-
10
-
-
0020673509
-
Effects of CDP-choline and CDP-ethanolamine on the alterations in rat brain lipid metabolism induced by global ischemia
-
Dorman RV, Dabrowiecki Z, Horrocks LA. Effects of CDP-choline and CDP-ethanolamine on the alterations in rat brain lipid metabolism induced by global ischemia. J Neurochem 1983; 40: 276-9.
-
(1983)
J Neurochem
, vol.40
, pp. 276-279
-
-
Dorman, R.V.1
Dabrowiecki, Z.2
Horrocks, L.A.3
-
11
-
-
0023606061
-
Effects of CDP-choline of phospholipase and cholinephosphotransferase activities following a cryogenic brain injury in the rabbit
-
Arrigoni E, Averet N, Cohadon F. Effects of CDP-choline of phospholipase and cholinephosphotransferase activities following a cryogenic brain injury in the rabbit. Biochem Pharmacol 1987; 36: 3697-700.
-
(1987)
Biochem Pharmacol
, vol.36
, pp. 3697-3700
-
-
Arrigoni, E.1
Averet, N.2
Cohadon, F.3
-
12
-
-
0020629538
-
'Cerebroactive' drugs: Clinical pharmacology and therapeutic role in cerebrovascular disorders
-
Spagnoli A, Tognoni G. 'Cerebroactive' drugs: clinical pharmacology and therapeutic role in cerebrovascular disorders. Drugs 1983; 26: 44-69.
-
(1983)
Drugs
, vol.26
, pp. 44-69
-
-
Spagnoli, A.1
Tognoni, G.2
|